HIV News and Research

RSS

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

The British Medical Association today (4 November 2004) calls on Health Secretary John Reid to deliver tough action to protect the nation's health, as he finalises the White Paper on Public Health for England.

4 Nov 2004

Californians say yes on 71

With a clear mandate, the voters of California yesterday overwhelmingly approved Proposition 71, the California Stem Cell Research and Cures Initiative.

4 Nov 2004

Medmira ships 100,000 rapid HIV tests to China

MedMira has announced that it has shipped 100,000 Rapid HIV Tests to one of its distributors in the People's Republic of China.

4 Nov 2004

Help for NHS staff bringing healthcare to the world's poor

NHS staff from England who are planning health projects in the world's poorest communities are being supported by a new Department of Health fund, now opening its second wave (3 November 2004).

3 Nov 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

Results of a study in this week’s issue of THE LANCET suggest that routine screening of blood samples to detect viral RNA among organ and tissue donors who do not have obvious signs of clinical disease would reduce the risk of disease transmission among transplant recipients.

29 Oct 2004

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

A potential new therapeutic approach to Alzheimer's disease protects brain cells in culture by drastically reducing the neurotoxic amyloid protein aggregates that are critical to the development of the disease.

29 Oct 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

New study of blood substitute for use in trauma cases

The Virginia Commonwealth University Medical Center launched a study Monday on an experimental blood substitute, PolyHeme, that will be given to critically injured and bleeding victims before they arrive at the hospital.

26 Oct 2004

A radical change is needed in the way TB is tackled globally

On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.

26 Oct 2004

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Highly active antiretroviral therapy (HAART) for the treatment of individuals infected by HIV-1 is limited by high costs, drug resistance, and drug-related toxicities. This has led researchers to investigate new treatment options, including ways to boost immune responses to better control HIV.

25 Oct 2004

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford’s Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.

25 Oct 2004

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

The Company is seeking accelerated approval of tipranavir and has requested a priority, six-month review of the NDA. Priority review designation is based upon whether a drug provides a significant improvement in the treatment of a serious or life-threatening disease.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

A new general medical journal launched this week with a non-traditional publishing model

A new general medical journal launched this week with a non-traditional publishing model is the latest top-tier venue for publishing important, peer-reviewed biomedical research, and is being called the first major, international journal to be introduced in more than 70 years.

22 Oct 2004

First public healthcare and HIV/AIDS programme in Kibera, Kenya

On October 21, in collaboration with the Kenyan Ministry of Health, the international humanitarian organization Medecins Sans Frontieres (MSF) opened a health centre providing public healthcare, including treatment for HIV/AIDS, for the residents of Kibera slum in Nairobi.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Misconceptions about sexual violence common among South African youth

Misconceptions about sexual violence and the risk of HIV infection and AIDS are common among South African youth, finds a study in this week's BMJ.

21 Oct 2004

Launch of an internet-based HIV/AIDS training resource database

A major barrier to access to care for HIV/AIDS patients in resource limited settings -- the lack of trained healthcare providers -- is now eased with the launch of an internet-based clinical training resource database.

19 Oct 2004

HIV News and Research

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

Californians say yes on 71

Medmira ships 100,000 rapid HIV tests to China

Help for NHS staff bringing healthcare to the world's poor

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

Cellular enzyme represents a potential new target for developing improved HIV drugs

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

New molecular tool to pinpoint DNA mutations among thousands of cells

New study of blood substitute for use in trauma cases

A radical change is needed in the way TB is tackled globally

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

Who should and who should not get a flu shot?

A new general medical journal launched this week with a non-traditional publishing model

First public healthcare and HIV/AIDS programme in Kibera, Kenya

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Misconceptions about sexual violence common among South African youth

Launch of an internet-based HIV/AIDS training resource database

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News